The hypothesis was tested that mucosal stimulation with unmatched mononuclear cells would induce systemic alloimmune responses. Rectal or vaginal mucosal administration of 104–107 unmatched mononuclear cells induced significant dose-dependent T-cell proliferation stimulated by the allogeneic cells in rhesus macaques. This was associated with a significant upregulation of CD8+ T-cell-derived suppressor factor, as well as the CC chemokines CCL3, CCL4 and CCL5. In addition, there was a dose-dependent increase in antibodies to CCR5. These responses were associated with decreased in vitro simian immunodeficiency virus (SIV) infectivity of CD4+ T cells. A further investigation of SIV infectivity of CD4+ T cells separated from multiparous macaques also showed significant inhibition compared with male macaques. It is suggested that vaginal or rectal exposure to allogeneic stimulation by a partner's HLA antigens in seminal fluid, as occurs during sexual intercourse, or immunization by semi-allogeneic fetuses in multiparous females may elicit protection against SIV or human immunodeficiency virus infection.
AmaraA.,
GallS. L.,
SchwartzO.,
SalameroJ.,
MontesM.,
LoetscherP.,
BaggioliniM.,
VirelizierJ. L.,
Arenzana-SeisdedosF.1997; HIV coreceptor downregulation as antiviral principle; SDF-1 α -dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186:139–146[CrossRef]
BergmeierL. A.,
WalkerJ.,
TaoL.,
CranageM. P.,
LehnerT.1994; Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with simian immunodeficiency virus. Immunology 83:213–220
BeyrerC.,
ArtensteinA. W.,
RugpaoS.9 other authors1999; Epidemiologic and biologic characterization of a cohort of human immunoficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 179:59–67[CrossRef]
BlattmanJ. N.,
AntiaR.,
SourdiveD. J. D.,
WangX.,
KaechS. M.,
Murali-KrishnaK.,
AltmanJ. D.,
AhmedR.2002; Estimating the precursor frequency of naïve antigen-specific CD8 T cells. J Exp Med 195:657–664[CrossRef]
BouhlalH.,
HociniH.,
Quillent-GregoireC.8 other authors2001; Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1. J Immunol 166:7606–7611[CrossRef]
BruhlP.,
KerschbaumA.,
ZimmermannK.,
EiblM. M.,
MannhalterJ. W.1996; Allostimulated lymphocytes inhibit replication of HIV type 1. AIDS Res Hum Retroviruses 12:31–37[CrossRef]
CarlsonJ. R.,
McGrawT. P.,
KeddieE.8 other authors1990; Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res Hum Retroviruses 6:1239–1246
CelumC. L.,
CoombsR. W.,
JonesM.7 other authors1994; Risk factors for repeatedly reactive HLA-1 EIA and intermediate western blot. A population-based case–control study. Arch Intern Med 154:1129–1137[CrossRef]
CocchiF.,
DeVicoA. L.,
Garzino-DemoA.,
AyraS. K.,
GalloR. C.,
LussoP.1995; Identification of RANTES, MIP-1 α and MIP-1 β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811–1815[CrossRef]
DoyleC. B.,
BhattacharyyaU.,
KentK. A.,
StottE. J.,
JonesI. M.1995; Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. J Virol 69:1256–1260
Garzino-DemoA.,
MossR. B.,
MargolickJ. B.7 other authors1999; Spontaneous and antigen-induced production of HIV-inhibitory β -chemokines are associated with AIDS-free status. Proc Natl Acad Sci U S A 96:11986–11991[CrossRef]
GohW. C.,
MarkeeJ.,
AkridgeR. E.8 other authors1999; Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J Infect Dis 179:548–557[CrossRef]
KaulR.,
PlummerF. A.,
KimaniJ.8 other authors2000; HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 164:1602–1611[CrossRef]
KindC.1995; Mother-to-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Paediatric AIDS Group of Switzerland. Eur J Pediatr 154:542–545[CrossRef]
KoelmanC. A.,
CoumansA. B. C.,
NijmanH. W.,
DoxiadisI. I. N.,
DekkerG. A.,
ClaasF. H. J.2000; Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid?. J Reprod Immunol 46:155–166[CrossRef]
LangloisA. J.,
WeinholdK. J.,
MatthewsT. J.,
GreenbergM. L.,
BolognesiD. P.1992; The ability of certain SIV vaccines to provoke reactions against normal cells. Science 255:292–293[CrossRef]
LehnerT.,
WangY.,
CranageM.11 other authors1996; Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 2:767–775[CrossRef]
LehnerT.,
WangY.,
DoyleC.,
TaoL.,
BergmeierL. A.,
MitchellE.,
BogersW. M. J. M.,
HeeneyJ.,
KellyC. G.1999; Induction of inhibitory antibodies to CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques. Eur J Immunol 29:2427–2435[CrossRef]
LehnerT.,
ShearerG. M.,
HackettC. J.,
SchultzA.,
SharmaO. K.2000a; Alloimmunization as a strategy for vaccine design against HIV/AIDS. AIDS Res Hum Retroviruses 16:309–313[CrossRef]
LehnerT.,
BergmeierL. A.,
WangY.,
TaoL.,
SinghM.,
SpallekR.,
van der ZeeR.2000b; Heat shock proteins generate β -chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol 30:594–603[CrossRef]
LehnerT.,
DoyleC.,
WangY.,
BabaahmadyK.,
WhittallT.,
TaoL.,
BergmeierL. A.,
KellyC.2001; Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the effects on simian immunodeficiency virus or HIV infectivity. J Immunol 166:7446–7455[CrossRef]
LevyJ. A.,
MackewiczC. E.,
BarkerE.1996; Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 17:217–224[CrossRef]
MacDonaldK. S.,
EmbreeJ.,
NjengaS.7 other authors1998; Mother–child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 177:551–556[CrossRef]
MackM.,
LuckowB.,
NelsonP. J.10 other authors1998; Aminooxypentase-RANTES induced CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 187:1215–1224[CrossRef]
MackewiczC. E.,
CraikC. S.,
LevyJ. A.2003; The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Proc Natl Acad Sci U S A 100:3433–3438[CrossRef]
Martin-VillaJ. M.,
LongasJ.,
Arnaiz-VillenaA.1999; Cyclic expression of HLA class I and II molecules on the surface of purified human spermatozoa and their control by serum inhibin B levels. Biol Reprod 61:1381–1386[CrossRef]
MazzoliS.,
TrabattoniD.,
Lo CaputoS.13 other authors1997; HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 3:1250–1257[CrossRef]
OttingN.,
HeijmansC. M.,
NoortR. C.,
de GrootN. G.,
DoxiadisG. G.,
van RoodJ. J.,
WatkinsD. I.,
BontropR. E.2005; Unparalleled complexity of the MHC class I region in rhesus macaques. Proc Natl Acad Sci U S A 102:1626–1631[CrossRef]
PetersB.,
WhittallT.,
BabaahmadyK.,
GrayK.,
VaughanR.,
LehnerT.2004; Effect of heterosexual intercourse in mucosal alloimmunisation and resistance to HIV-1 infection. Lancet 363:518–524[CrossRef]
PintoL. A.,
SullivanJ.,
BerzofskyJ. A.,
ClericiM.,
KesslerH. A.,
LandayA. L.,
ShearerG. M.1995; ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 96:867–876[CrossRef]
PolyanskayaN.,
SharpeS. A.,
CookN.,
LeechS.,
CranageM. P.2003; Infection of macaques with simian immunodeficiency virus induces a species-specific antibody response to major histocompatibility complex class I and II molecules. J Gen Virol 84:1671–1676[CrossRef]
QuayleA. J.,
XuC.,
MayerK. H.,
AndersonD. J.1997; T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 176:960–968[CrossRef]
RugelesM. T.,
TrubeyC. M.,
BedoyaV. I.,
PintoL. A.,
OppenheimJ. J.,
RybakS. M.,
ShearerG. M.2003; Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS 17:481–486[CrossRef]
SuchinE. J.,
LangmuirP. B.,
PalmerE.,
SayeghM. H.,
WellsA. D.,
TurkaL. A.2001; Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166:973–981[CrossRef]
Vila-CoroA. J.,
MelladoM.,
Martin de AnaA.,
LucasP.,
del RealG.,
Martinez-AC.,
Rodriguez-FradeJ. M.2000; HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc Natl Acad Sci U S A 97:3388–3393[CrossRef]
WangY.,
TaoL.,
MitchellE.7 other authors1998; Generation of CD8 suppressor factor and β -chemokines, induced by xenogeneic immunization. in the prevention of SIV infection in macaques. Proc Natl Acad Sci U S A955223–5228[CrossRef]
WangY.,
TaoL.,
MitchellE.,
BraveryC.,
BerlingieriP.,
ArmstrongP.,
VaughanR.,
UnderwoodJ.,
LehnerT.1999a; Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med 5:1004–1009[CrossRef]
WangY.,
TaoL.,
MitchellE.,
BergmeierL.,
DoyleC.,
LehnerT.1999b; The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis. Vaccine 17:1826–1836[CrossRef]